Female Libido Drug Maker Appealing FDA Decision
Dec. 12, 2013 -- It's not clear whether the benefits of a drug meant to increase sexual desire in women outweigh the risks, the U.S. Food and Drug Administration says.
The agency considers the effectiveness of Sprout Pharmaceuticals' drug flibanserin to be "modest," while side effects include fatigue, dizziness and nausea, the Associated Press reported.
The daily pill was developed to boost libido in women by targeting brain chemicals linked to mood and appetite.
An October letter from the FDA to Sprout denied approval of the drug and requested more information. The company is appealing the decision, but it appears to have a low chance of success. Only 3 of 17 appeals considered last year by the FDA were successful, the AP reported.
So far, all attempts to develop a drug to increase women's sexual desire have been unsuccessful.